Ensaios clínicos de Enxaqueca em Flórida
12 estudos para Enxaqueca estão buscando participantes em locais em Flórida.
Cidades em Flórida
Texto oficial do estudo (Inglês)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Direct Helpers Research Center, Hialeah
- D&H Tamarac Research Center LLC, Tamarac
- Santos Research Center, CORP, Tampa
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- South Florida Research Phase I-IV, Inc, Miami
- Aqualane Clinical Research, Naples
- Clinical Associates of Orlando, LLC, Orlando
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- South Florida Research Phase I-IV, Inc, Miami
- Clinical Associates of Orlando, LLC, Orlando
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Northwest Florida Clinical Research Group, LLC /ID# 270833, Gulf Breeze
- My Preferred Research /ID# 270312, Miami
- Encore Medical Research - Weston /ID# 271139, Weston
- e mais 1
RecrutandoFase 3
Idades de 12 a 17 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Memorial Healthcare, Hollywood
- Mayo Clinic Florida, Jacksonville
- Apple Med Research, Miami
- e mais 1
RecrutandoFase 4
Idades de 18 a 70 · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Encore Medical Research of Boynton Beach LLC /ID# 246833, Boynton Beach
- Gulf Coast Clinical Research Center /ID# 230020, Fort Myers
- AGA Clinical Trials /ID# 230554, Hialeah
- e mais 9
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05125302Study of EVO756 in Adults With Migraine
- Clinical Neuroscience Solutions, Inc., Jacksonville
- Apple Medical Research Group, Inc, Miami
- Blessed Healthcase & Research, Miami
- e mais 4
RecrutandoFase 2
Idades de 18 a 64 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07616128Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Neuroscineces Solutions - Orlando, Orlando
- Clinical Neuroscineces Solutions, Orlando
RecrutandoFase 2
Idades de 18 a 65 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07646613A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- NW FL Clinical Research Group, LLC, Gulf Breeze
- AGA Clinical Trials - Hialeah - 4980 W 10th Ave, Hialeah
- University of South Florida, Tampa
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Homestead Associates in Research, Inc., Homestead
- Florida Neurology - Lake Mary, Lake Mary
- Flourish Research - Miami, LLC dba Flourish Research, Miami
- e mais 2
RecrutandoFase 2
Idades de 18 a 70 · Todos os sexos · Atualizado em 19 de mai. de 2026 · NCT06602479Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- University of Miami, Miller School of Medicine, Miami
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2025 · NCT07159750Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #14, Tampa
RecrutandoFase 4
Idades de 6 a 11 · Todos os sexos · Atualizado em 27 de jan. de 2025 · NCT04748601Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.